Another limitation of GLP-1 RAs is that discontinuation commonly leads to substantial body weight regain, and many patients who regain weight subsequently restart GLP-1 RA therapy, resulting in a recurrent cycle of body weight loss and gain [10]
The natural next question is if these treatments can help people with PWS and their families in the treatment of hyperphagia, obesity, and obesity-associated complications
Testosterone directly acts on ILC2s by inhibiting their proliferation, Dr Seillet said
Redox Rep 5:1467 Fulle S, Mecocci P, Fan G, Vecchiet I, Vecchini A, Racciotti D, Cherubini A, Pizzigallo E, Vecchiet L, Senin U, Beal MF (2000) Specific oxidative alterations in vastus lateralis muscle of patients with the diagnosis of chronic fatigue syndrome
In this regard, we have further discussed and systematically elaborated